Skip to content

ADMA Biologics ADMA Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
Zymeworks logo
ZymeworksZYME

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount?
ADMA Biologics (ADMA) reported effective income tax rate reconciliation, other adjustments, amount of $154K in Q4 2025.
How has ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount changed year-over-year?
ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount decreased by 28.5% year-over-year, from $215.5K to $154K.
What is the long-term trend for ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount?
Over 2 years (2023 to 2025), ADMA Biologics's effective income tax rate reconciliation, other adjustments, amount has grown at a -22.1% compound annual growth rate (CAGR), from $1.01M to $616K.